Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 4 TO FORM S-1 - MARRONE BIO INNOVATIONS INC | d329931ds1a.htm |
| EX-10.24 - EX-10.24 - MARRONE BIO INNOVATIONS INC | d329931dex1024.htm |
| EX-10.28 - EX-10.28 - MARRONE BIO INNOVATIONS INC | d329931dex1028.htm |
| EX-10.26 - EX-10.26 - MARRONE BIO INNOVATIONS INC | d329931dex1026.htm |
| EX-10.27 - EX-10.27 - MARRONE BIO INNOVATIONS INC | d329931dex1027.htm |
| EX-10.29 - EX-10.29 - MARRONE BIO INNOVATIONS INC | d329931dex1029.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 17, 2013 (except Note 17, as to which the date is , 2013), in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-189753) and related Prospectus of Marrone Bio Innovations, Inc. for the registration of 4,830,000 shares of its common stock.
Ernst & Young LLP
Sacramento, California
The foregoing consent is in the form that will be signed upon the completion of the restatement of capital accounts described in Note 17 to the consolidated financial statements.
/s/ Ernst & Young LLP
Sacramento, California
July 30, 2013